cbdMD (YCBD) Operating Income (2016 - 2025)
cbdMD (YCBD) reported Operating Income of -$286288.0 for Q4 2025, down 231.84% on a YoY basis from $217142.3 in Q4 2024, and up 58.26% sequentially from -$685816.0 in Q3 2025.
cbdMD (YCBD) Operating Income (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Operating Income data on file, last reported at -$286288.0 in Q4 2025.
- For the quarter ending Q4 2025, Operating Income fell 231.84% year-over-year to -$286288.0; the trailing twelve-month figure through Dec 2025 stood at -$2.4 million (down 1.15% YoY), and the FY2025 full-year result was -$2.2 million, up 34.77% from the prior year.
- Operating Income climbed to -$286288.0 in Q4 2025, from -$685816.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$86272.0 in Q4 2024 to a low of -$33.1 million in Q2 2022.
- A 5-year average of -$6.2 million and a median of -$1.7 million in 2023 frame the typical range for Operating Income.
- Across the five-year window, Operating Income tumbled 1328.74% in 2021 and surged 97.92% in 2024, its largest moves.
- Tracing YCBD's Operating Income over 5 years: stood at -$25.1 million in 2021, then surged by 83.91% to -$4.0 million in 2022, then jumped by 73.66% to -$1.1 million in 2023, then surged by 91.91% to -$86272.0 in 2024, then slumped by 231.84% to -$286288.0 in 2025.
- Business Quant data shows YCBD's Operating Income at -$286288.0 in Q4 2025, -$685816.0 in Q3 2025, and -$904686.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | -286,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -286,288.00 |
| Sep 30, 2025 | -685,816.00 |
| Jun 30, 2025 | -904,686.00 |
| Mar 31, 2025 | -485,816.00 |
| Dec 31, 2024 | -86,272.00 |
| Sep 30, 2024 | -316,555.00 |
| Jun 30, 2024 | -382,028.00 |
| Mar 31, 2024 | -1.55 Mn |
| Dec 31, 2023 | -1.07 Mn |
| Sep 30, 2023 | -15.22 Mn |
| Jun 30, 2023 | -1.82 Mn |
| Mar 31, 2023 | -1.40 Mn |
| Dec 31, 2022 | -4.05 Mn |
| Sep 30, 2022 | -14.98 Mn |
| Jun 30, 2022 | -33.13 Mn |
| Mar 31, 2022 | -5.01 Mn |
| Dec 31, 2021 | -25.15 Mn |
| Sep 30, 2021 | -7.01 Mn |
| Jun 30, 2021 | -6.68 Mn |
| Mar 31, 2021 | -4.17 Mn |